Heartflow Inc（HTFL）股票分析HTFLHeartflow Inc

Heartflow, Inc. is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). Its novel Heartflow Platform uses AI and advanced computational fluid dynamics to create a personalized 3D model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Heartflow RoadMap Analysis, Heartflow FFRCT Analysis, Heartflow Plaque Analysis and Heartflow PCI Navigator. Its Heartflow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. Heartflow RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review. Heartflow FFRCT Analysis calculates blood flow and pinpoints clinically significant CAD. It operates in the Healthcare sector.

HeartFlow Inc is a good buy right now, trading at $56.71 with a strong RSI of 74.34, indicating bullish momentum. The company reported a 48% year-over-year revenue growth to $64.1 million in Q2 2026 and improved its gross margin to 83%, showcasing operational efficiency. However, the main risk is the negative net income, which stands at -$15.74 million for Q2 2026, indicating ongoing losses that investors should monitor closely.